Emergent Biosolutions Inc (EBS)
Fair Value22.1% Upside
Undervalued
Analyst165.8% Upside
Market Cap248.2 M
P/E-1.3x
Yield0.0%
HealthGood
NYSE
Featured in
High-Beta Stocks
Small-Cap Stocks
Lineage Cell Therapeutics Inc (LCTX)
Fair Value15.9% Upside
Fair
Analyst397.7% Upside
Market Cap278.2 M
P/E-8.7x
Yield0.0%
HealthWeak
NYSE
Featured in
High-Beta Stocks
Protalix Biotherapeutics Inc (PLX)
Analyst344.4% Upside
Market Cap198.2 M
P/E13.0x
Yield0.0%
HealthGreat
NYSE
Featured in
Overvalued Stocks
High-Beta Stocks
Biohaven Pharmaceutical Holding Co Ltd (BHVN)
Fair Value-14.0% Downside
Fair
Analyst55.8% Upside
Market Cap2.207 B
P/E-3.4x
Yield0.0%
HealthWeak
NYSE
Featured in
High-Beta Stocks
Adc Therapeutics SA (ADCT)
Fair Value11.4% Upside
Fair
Analyst346.4% Upside
Market Cap143.7 M
P/E-1.1x
Yield0.0%
HealthFair
NYSE
Featured in
High-Beta Stocks
Annovis Bio Inc (ANVS)
Fair Value-3.0% Downside
Fair
Analyst491.4% Upside
Market Cap79.979 M
P/E-2.0x
Yield0.0%
HealthWeak
NYSE
Featured in
High-Beta Stocks
Maia Biotechnology Inc (MAIA)
Fair Value-5.9% Downside
Fair
Analyst769.9% Upside
Market Cap86.337 M
P/E-3.5x
Yield0.0%
HealthFair
NYSE
Featured in
High-Beta Stocks
Pelthos Therapeutics Inc (PTHS)
Fair Value15.2% Upside
Fair
Analyst103.8% Upside
Market Cap98.569 M
P/E-1.9x
Yield0.0%
HealthFair
NYSE
Featured in
High-Beta Stocks
High-Beta Momentum
